Loading clinical trials...

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT05932641

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

AZD3152 is being evaluated for administration to prevent COVID-19. This Phase I study will gather important information on the safety and tolerability of AZD3152 as well as relevant data on the PK, PD...

Lead sponsor: AstraZeneca•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

NCT06160128 · COVID-19, SARS-CoV-2 Infection, RSV, and more

COMPLETEDPhase 2

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

NCT06057064 · COVID-19, SARS-CoV-2

COMPLETEDPhase 2/3

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

NCT05648110 · COVID-19, SARS-CoV-2

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 27, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment24

Start dateJul 2023

Last updatedDec 27, 2024

Condition

COVID-19, SARS-CoV-2

Locations shown

Research Site

Fukuoka

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 27, 2024Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions